Crispr Therapeutics shares owned by State Street Corporation
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by State Street Corporation
from 13F filings
Historical chart of State Street Corporation investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by State Street Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $260M | 4.0M | 64.81 |
| 2025-06-30 | $159M | 3.3M | 48.64 |
| 2025-03-31 | $82M | 2.4M | 34.03 |
| 2024-12-31 | $98M | 2.5M | 39.36 |
| 2024-09-30 | $141M | 3.0M | 46.98 |
| 2024-06-30 | $129M | 2.4M | 54.01 |
| 2024-03-31 | $102M | 1.5M | 68.16 |
| 2023-12-31 | $110M | 1.8M | 62.60 |
| 2023-09-30 | $86M | 1.9M | 45.39 |
| 2023-06-30 | $92M | 1.6M | 56.14 |
| 2023-03-31 | $90M | 2.0M | 45.23 |
| 2022-12-31 | $85M | 2.1M | 40.65 |
| 2022-09-30 | $103M | 1.6M | 65.35 |
| 2022-06-30 | $95M | 1.6M | 60.77 |
| 2022-03-31 | $30M | 478k | 62.77 |
| 2021-12-31 | $16M | 208k | 75.78 |
| 2021-09-30 | $18M | 163k | 111.93 |
| 2021-06-30 | $24M | 151k | 161.89 |
| 2021-03-31 | $17M | 142k | 121.85 |
| 2020-12-31 | $21M | 135k | 153.11 |
| 2020-09-30 | $12M | 141k | 83.64 |
| 2020-06-30 | $8.9M | 121k | 73.49 |
| 2020-03-31 | $3.0M | 71k | 42.41 |
| 2019-12-31 | $2.9M | 48k | 60.91 |
| 2019-03-31 | $931k | 26k | 35.73 |
| 2018-12-31 | $753k | 26k | 28.57 |
| 2018-09-30 | $1.2M | 28k | 44.38 |
| 2018-06-30 | $1.4M | 24k | 58.76 |